Actinium Pharmaceuticals, Inc.
Hedge Funds Holdings
Last updated:
Actinium Pharmaceuticals, Inc.‘s stocks are currently a part of 33 hedge funds’ portfolios, which represents 6.16% of the total amount of its stocks outstanding. This makes up a total of 1.48M shares of Actinium Pharmaceuticals, Inc.. Compared to the previous quarter, the number fell by -66.87% or -3.00M shares fewer. As for the holding position changes, 30.3% (10) of current hedge fund investors increased the number of shares held, 24.24% (8) of current holders sold a part of the shares held, and 21.21% (7) closed the holdings completely. 7 hedge funds are new holders of Actinium Pharmaceuticals, Inc. stock in Q1 2023, it is 21.21% of total holders.
Hedge funds holding Actinium Pharmaceuticals (Q2 2018 – Q1 2023)
| Q2 2018 | 42 |
|---|---|
| Q3 2018 | 41 |
| Q4 2018 | 39 |
| Q1 2019 | 42 |
| Q2 2019 | 43 |
| Q3 2019 | 39 |
| Q4 2019 | 41 |
| Q1 2020 | 35 |
| Q2 2020 | 56 |
| Q3 2020 | 35 |
| Q4 2020 | 42 |
| Q1 2021 | 32 |
| Q2 2021 | 30 |
| Q3 2021 | 38 |
| Q4 2021 | 33 |
| Q1 2022 | 33 |
| Q2 2022 | 40 |
| Q3 2022 | 47 |
| Q4 2022 | 58 |
| Q1 2023 | 33 |
Hedge funds changes in Actinium Pharmaceuticals positions (Q2 2018 – Q1 2023)
| Q2 2018 | 15 | 6 | 8 | 8 | 5 |
|---|---|---|---|---|---|
| Q3 2018 | 7 | 15 | 4 | 8 | 7 |
| Q4 2018 | 6 | 5 | 12 | 7 | 9 |
| Q1 2019 | 6 | 6 | 9 | 4 | 17 |
| Q2 2019 | 6 | 9 | 6 | 5 | 17 |
| Q3 2019 | 3 | 8 | 5 | 7 | 16 |
| Q4 2019 | 9 | 7 | 7 | 7 | 11 |
| Q1 2020 | 5 | 7 | 7 | 8 | 8 |
| Q2 2020 | 22 | 19 | 1 | 3 | 11 |
| Q3 2020 | 33 | 1 | 0 | 54 | -53 |
| Q4 2020 | 17 | 13 | 5 | 10 | -3 |
| Q1 2021 | 7 | 7 | 9 | 17 | -8 |
| Q2 2021 | 4 | 15 | 2 | 6 | 3 |
| Q3 2021 | 13 | 12 | 5 | 4 | 4 |
| Q4 2021 | 5 | 9 | 9 | 11 | -1 |
| Q1 2022 | 5 | 11 | 6 | 5 | 6 |
| Q2 2022 | 11 | 14 | 3 | 4 | 8 |
| Q3 2022 | 11 | 17 | 8 | 4 | 7 |
| Q4 2022 | 16 | 24 | 9 | 5 | 4 |
| Q1 2023 | 7 | 10 | 8 | 7 | 1 |
Hedge funds changes in Actinium Pharmaceuticals stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 32,000 | 0 |
|---|---|---|
| Q3 2018 | 180,000 | 7,000 |
| Q4 2018 | 91,000 | 0 |
| Q1 2019 | 78,000 | 0 |
| Q2 2019 | 42,000 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 1,000 |
| Q1 2020 | 0 | 1,000 |
| Q2 2020 | 5,000 | 0 |
| Q3 2020 | 1,352,000 | 498,000 |
| Q4 2020 | 3,160,000 | 2,702,000 |
| Q1 2021 | 16,880,000 | 555,000 |
| Q2 2021 | 2,811,000 | 689,000 |
| Q3 2021 | 4,621,000 | 4,319,000 |
| Q4 2021 | 3,013,000 | 2,841,000 |
| Q1 2022 | 5,004,000 | 1,302,000 |
| Q2 2022 | 3,466,000 | 1,636,000 |
| Q3 2022 | 3,444,000 | 2,225,000 |
| Q4 2022 | 3,464,140 | 4,175,540 |
| Q1 2023 | 409,232,000 | 632,424,000 |